Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls.

Cardiovascular diagnosis and therapy

Shufelt CL, Thomson LE, Goykhman P, Agarwal M, Mehta PK, Sedlak T, Li N, Gill E, Samuels B, Azabal B, Kar S, Kothawade K, Minissian M, Slomka P, Berman DS, Bairey Merz CN.
PMID: 24282764
Cardiovasc Diagn Ther. 2013 Sep;3(3):153-60. doi: 10.3978/j.issn.2223-3652.2013.08.02.

OBJECTIVE: We sought to comparatively assess cardiac magnetic resonance imaging (CMRI) myocardial perfusion reserve index (MPRI) in women with confirmed microvascular coronary dysfunction (MCD) cases and reference control women.BACKGROUND: Women with signs or symptoms of myocardial ischemia in the...

Cite
Shufelt CL, Thomson LE, Goykhman P, et al. Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. Cardiovasc Diagn Ther. 2013;3(3):153-60doi: 10.3978/j.issn.2223-3652.2013.08.02.
Shufelt, C. L., Thomson, L. E., Goykhman, P., Agarwal, M., Mehta, P. K., Sedlak, T., Li, N., Gill, E., Samuels, B., Azabal, B., Kar, S., Kothawade, K., Minissian, M., Slomka, P., Berman, D. S., & Bairey Merz, C. N. (2013). Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. Cardiovascular diagnosis and therapy, 3(3), 153-60. https://doi.org/10.3978/j.issn.2223-3652.2013.08.02
Shufelt, Chrisandra L, et al. "Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls." Cardiovascular diagnosis and therapy vol. 3,3 (2013): 153-60. doi: https://doi.org/10.3978/j.issn.2223-3652.2013.08.02
Shufelt CL, Thomson LE, Goykhman P, Agarwal M, Mehta PK, Sedlak T, Li N, Gill E, Samuels B, Azabal B, Kar S, Kothawade K, Minissian M, Slomka P, Berman DS, Bairey Merz CN. Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. Cardiovasc Diagn Ther. 2013 Sep;3(3):153-60. doi: 10.3978/j.issn.2223-3652.2013.08.02. PMID: 24282764; PMCID: PMC3839208.
Copy Download .nbib Format: NLM
Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction.

Cardiovascular diagnosis and therapy

Agarwal M, Shufelt C, Mehta PK, Gill E, Berman DS, Li D, Sharif B, Li N, Bairey Merz CN, Thomson LE.
PMID: 24282763
Cardiovasc Diagn Ther. 2013 Sep;3(3):146-52. doi: 10.3978/j.issn.2223-3652.2013.08.01.

UNLABELLED: Women with myocardial ischemia without obstructive coronary artery disease (CAD) often have microvascular coronary dysfunction (MCD). Traditional cardiac risk factors (RFs) contribute modestly to MCD detected by invasive coronary reactivity testing (CRT). Cardiac magnetic resonance imaging (CMRI) is...

Cite
Agarwal M, Shufelt C, Mehta PK, et al. Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction. Cardiovasc Diagn Ther. 2013;3(3):146-52doi: 10.3978/j.issn.2223-3652.2013.08.01.
Agarwal, M., Shufelt, C., Mehta, P. K., Gill, E., Berman, D. S., Li, D., Sharif, B., Li, N., Bairey Merz, C. N., & Thomson, L. E. (2013). Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction. Cardiovascular diagnosis and therapy, 3(3), 146-52. https://doi.org/10.3978/j.issn.2223-3652.2013.08.01
Agarwal, Megha, et al. "Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction." Cardiovascular diagnosis and therapy vol. 3,3 (2013): 146-52. doi: https://doi.org/10.3978/j.issn.2223-3652.2013.08.01
Agarwal M, Shufelt C, Mehta PK, Gill E, Berman DS, Li D, Sharif B, Li N, Bairey Merz CN, Thomson LE. Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction. Cardiovasc Diagn Ther. 2013 Sep;3(3):146-52. doi: 10.3978/j.issn.2223-3652.2013.08.01. PMID: 24282763; PMCID: PMC3839214.
Copy Download .nbib Format: NLM
Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes.

Metabolomics : Official journal of the Metabolomic Society

Vaitheesvaran B, Chueh FY, Xu J, Trujillo C, Saad MF, Lee WN, McGuinness OP, Kurland IJ.
PMID: 20445758
Metabolomics. 2010 Jun;6(2):180-190. doi: 10.1007/s11306-009-0190-2. Epub 2009 Nov 12.

In vivo insulin sensitivity can be assessed using "open loop" clamp or "closed loop" methods. Open loop clamp methods are static, and fix plasma glucose independently from plasma insulin. Closed loop methods are dynamic, and assess glucose disposal in...

Cite
Vaitheesvaran B, Chueh FY, Xu J, et al. Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes. Metabolomics. 2009;6(2):180-190doi: 10.1007/s11306-009-0190-2.
Vaitheesvaran, B., Chueh, F. Y., Xu, J., Trujillo, C., Saad, M. F., Lee, W. N., McGuinness, O. P., & Kurland, I. J. (2010). Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes. Metabolomics : Official journal of the Metabolomic Society, 6(2), 180-190. https://doi.org/10.1007/s11306-009-0190-2
Vaitheesvaran, Bhavapriya, et al. "Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes." Metabolomics : Official journal of the Metabolomic Society vol. 6,2 (2010): 180-190. doi: https://doi.org/10.1007/s11306-009-0190-2
Vaitheesvaran B, Chueh FY, Xu J, Trujillo C, Saad MF, Lee WN, McGuinness OP, Kurland IJ. Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes. Metabolomics. 2010 Jun;6(2):180-190. doi: 10.1007/s11306-009-0190-2. Epub 2009 Nov 12. PMID: 20445758; PMCID: PMC2862950.
Copy Download .nbib Format: NLM
Identifying association under a previous linkage peak on chromosome 16 for body mass index using cross-sectional and longitudinal data of the Framingham Heart Study.

BMC proceedings

Li X, Mei L, Yang K, Rotter JI, Guo X.
PMID: 20017965
BMC Proc. 2009 Dec 15;3:S101. doi: 10.1186/1753-6561-3-s7-s101.

We performed association analysis under a previous linkage peak on chromosome 16 with genome-wide single-nucleotide polymorphism (SNP) data to identify genetic variants underlying body mass index (BMI). Data from all subjects with baseline measures and a subgroup who had...

Cite
Li X, Mei L, Yang K, et al. Identifying association under a previous linkage peak on chromosome 16 for body mass index using cross-sectional and longitudinal data of the Framingham Heart Study. BMC Proc. 2009;3:S101doi: 10.1186/1753-6561-3-s7-s101.
Li, X., Mei, L., Yang, K., Rotter, J. I., & Guo, X. (2009). Identifying association under a previous linkage peak on chromosome 16 for body mass index using cross-sectional and longitudinal data of the Framingham Heart Study. BMC proceedings, 3S101. https://doi.org/10.1186/1753-6561-3-s7-s101
Li, Xiaohui, et al. "Identifying association under a previous linkage peak on chromosome 16 for body mass index using cross-sectional and longitudinal data of the Framingham Heart Study." BMC proceedings vol. 3 (2009): S101. doi: https://doi.org/10.1186/1753-6561-3-s7-s101
Li X, Mei L, Yang K, Rotter JI, Guo X. Identifying association under a previous linkage peak on chromosome 16 for body mass index using cross-sectional and longitudinal data of the Framingham Heart Study. BMC Proc. 2009 Dec 15;3:S101. doi: 10.1186/1753-6561-3-s7-s101. PMID: 20017965; PMCID: PMC2795872.
Copy Download .nbib Format: NLM
Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.

Journal of cachexia, sarcopenia and muscle

Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP, Kalantar-Zadeh K.
PMID: 22777757
J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):19-29. doi: 10.1007/s13539-012-0079-1. Epub 2012 Jul 10.

BACKGROUND: Higher muscle mass is associated with better outcomes and longevity in patients with chronic disease states. Imaging studies such as dual-energy X-ray absorptiometry (DEXA) are among the gold standard methods for assessing body fat and lean body mass...

Cite
Patel SS, Molnar MZ, Tayek JA, et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2012;4(1):19-29doi: 10.1007/s13539-012-0079-1.
Patel, S. S., Molnar, M. Z., Tayek, J. A., Ix, J. H., Noori, N., Benner, D., Heymsfield, S., Kopple, J. D., Kovesdy, C. P., & Kalantar-Zadeh, K. (2013). Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. Journal of cachexia, sarcopenia and muscle, 4(1), 19-29. https://doi.org/10.1007/s13539-012-0079-1
Patel, Sapna S, et al. "Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature." Journal of cachexia, sarcopenia and muscle vol. 4,1 (2013): 19-29. doi: https://doi.org/10.1007/s13539-012-0079-1
Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP, Kalantar-Zadeh K. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):19-29. doi: 10.1007/s13539-012-0079-1. Epub 2012 Jul 10. PMID: 22777757; PMCID: PMC3581614.
Copy Download .nbib Format: NLM
Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans.

Clinical practice (London, England)

Ghanaat F, Tayek JA.
PMID: 29670744
Clin Pract (Lond). 2017;14(5):296-301. doi: 10.4172/clinical-practice.1000125.

Well-established risk factors for aspergillosis include HIV, cancer, recent corticosteroid (prednisone) therapy, chemotherapy, or thoracic surgery. Non-established risk factors may include weight loss and a history of diabetes. Twenty-three patients without the classical risk factors for IA were identified...

Cite
Ghanaat F, Tayek JA. Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans. Clin Pract (Lond). 2017;14(5):296-301doi: 10.4172/clinical-practice.1000125.
Ghanaat, F., & Tayek, J. A. (2017). Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans. Clinical practice (London, England), 14(5), 296-301. https://doi.org/10.4172/clinical-practice.1000125
Ghanaat, Farhad, and Tayek, John A. "Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans." Clinical practice (London, England) vol. 14,5 (2017): 296-301. doi: https://doi.org/10.4172/clinical-practice.1000125
Ghanaat F, Tayek JA. Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans. Clin Pract (Lond). 2017;14(5):296-301. doi: 10.4172/clinical-practice.1000125. PMID: 29670744; PMCID: PMC5901980.
Copy Download .nbib Format: NLM
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.

European heart journal

Shimokawa H, Suda A, Takahashi J, Berry C, Camici PG, Crea F, Escaned J, Ford T, Yii E, Kaski JC, Kiyooka T, Mehta PK, Ong P, Ozaki Y, Pepine C, Rimoldi O, Safdar B, Sechtem U, Tsujita K, Yasuda S, Beltrame JF, Merz CNB.
PMID: 34038937
Eur Heart J. 2021 Nov 21;42(44):4592-4600. doi: 10.1093/eurheartj/ehab282.

AIMS: To provide multi-national, multi-ethnic data on the clinical characteristics and prognosis of patients with microvascular angina (MVA).METHODS AND RESULTS: The Coronary Vasomotor Disorders International Study Group proposed the diagnostic criteria for MVA. We prospectively evaluated the clinical characteristics...

Cite
Shimokawa H, Suda A, Takahashi J, et al. Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. Eur Heart J. 2021;42(44):4592-4600doi: 10.1093/eurheartj/ehab282.
Shimokawa, H., Suda, A., Takahashi, J., Berry, C., Camici, P. G., Crea, F., Escaned, J., Ford, T., Yii, E., Kaski, J. C., Kiyooka, T., Mehta, P. K., Ong, P., Ozaki, Y., Pepine, C., Rimoldi, O., Safdar, B., Sechtem, U., Tsujita, K., Yasuda, S., Beltrame, J. F., & Merz, C. N. B. (2021). Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. European heart journal, 42(44), 4592-4600. https://doi.org/10.1093/eurheartj/ehab282
Shimokawa, Hiroaki, et al. "Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group." European heart journal vol. 42,44 (2021): 4592-4600. doi: https://doi.org/10.1093/eurheartj/ehab282
Shimokawa H, Suda A, Takahashi J, Berry C, Camici PG, Crea F, Escaned J, Ford T, Yii E, Kaski JC, Kiyooka T, Mehta PK, Ong P, Ozaki Y, Pepine C, Rimoldi O, Safdar B, Sechtem U, Tsujita K, Yasuda S, Beltrame JF, Merz CNB. Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. Eur Heart J. 2021 Nov 21;42(44):4592-4600. doi: 10.1093/eurheartj/ehab282. PMID: 34038937; PMCID: PMC8633728.
Copy Download .nbib Format: NLM
Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal.

Journal of diabetes, metabolic disorders & control

Tayek CJ, Cherukuri L, Hamal S, Tayek JA.
PMID: 31404422
J Diabetes Metab Disord Control. 2018;5(4):113-117. doi: 10.15406/jdmdc.2018.05.00148. Epub 2018 Jul 20.

Prandial insulin has been essential for the improved management of the type 1 diabetic patient. Interestingly, many studies have evaluated the addition of prandial insulin to the type 2 diabetic patients with improved control. The greatest drop in A1c...

Cite
Tayek CJ, Cherukuri L, Hamal S, et al. Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal. J Diabetes Metab Disord Control. 2018;5(4):113-117doi: 10.15406/jdmdc.2018.05.00148.
Tayek, C. J., Cherukuri, L., Hamal, S., & Tayek, J. A. (2018). Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal. Journal of diabetes, metabolic disorders & control, 5(4), 113-117. https://doi.org/10.15406/jdmdc.2018.05.00148
Tayek, Chandler J, et al. "Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal." Journal of diabetes, metabolic disorders & control vol. 5,4 (2018): 113-117. doi: https://doi.org/10.15406/jdmdc.2018.05.00148
Tayek CJ, Cherukuri L, Hamal S, Tayek JA. Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal. J Diabetes Metab Disord Control. 2018;5(4):113-117. doi: 10.15406/jdmdc.2018.05.00148. Epub 2018 Jul 20. PMID: 31404422; PMCID: PMC6688759.
Copy Download .nbib Format: NLM
Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.

Current treatment options in cardiovascular medicine

Xie Y, Collins WJ, Audeh MW, Shiao SL, Gottlieb RA, Goodman MT, Merz CN, Mehta PK.
PMID: 26490280
Curr Treat Options Cardiovasc Med. 2015 Dec;17(12):60. doi: 10.1007/s11936-015-0421-y.

OPINION STATEMENT: Cardiovascular disease (CVD) and breast cancer cause substantial morbidity and mortality in women and are major public health concerns in the USA. While aggressive screening and targeted, advanced treatment for breast cancer have had a measurable impact...

Cite
Xie Y, Collins WJ, Audeh MW, et al. Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology. Curr Treat Options Cardiovasc Med. 2015;17(12):60doi: 10.1007/s11936-015-0421-y.
Xie, Y., Collins, W. J., Audeh, M. W., Shiao, S. L., Gottlieb, R. A., Goodman, M. T., Merz, C. N., & Mehta, P. K. (2015). Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology. Current treatment options in cardiovascular medicine, 17(12), 60. https://doi.org/10.1007/s11936-015-0421-y
Xie, Yu, et al. "Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology." Current treatment options in cardiovascular medicine vol. 17,12 (2015): 60. doi: https://doi.org/10.1007/s11936-015-0421-y
Xie Y, Collins WJ, Audeh MW, Shiao SL, Gottlieb RA, Goodman MT, Merz CN, Mehta PK. Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology. Curr Treat Options Cardiovasc Med. 2015 Dec;17(12):60. doi: 10.1007/s11936-015-0421-y. PMID: 26490280; PMCID: PMC6364685.
Copy Download .nbib Format: NLM
Role of Stress Cardiac Magnetic Resonance Imaging in Women with Suspected Ischemia but No Obstructive Coronary Artery Disease.

Journal of radiology nursing

Jalnapurkar S, Zarrini P, Mehta PK, Thomson LEJ, Agarwal M, Samuels BA, Shufelt CL, Eastwood JA, Berman D, Merz NB, Minissian MB.
PMID: 29081724
J Radiol Nurs. 2017 Sep;36(3):180-183. doi: 10.1016/j.jradnu.2017.04.016. Epub 2017 Aug 30.

OBJECTIVE: Signs and symptoms of ischemia but no obstructive coronary artery disease (CAD) is often a diagnostic dilemma in women. The use of stress cardiac magnetic resonance imaging (CMRI) for advanced diagnostic assessment in these patients is a non-ionizing...

Cite
Jalnapurkar S, Zarrini P, Mehta PK, et al. Role of Stress Cardiac Magnetic Resonance Imaging in Women with Suspected Ischemia but No Obstructive Coronary Artery Disease. J Radiol Nurs. 2017;36(3):180-183doi: 10.1016/j.jradnu.2017.04.016.
Jalnapurkar, S., Zarrini, P., Mehta, P. K., Thomson, L. E. J., Agarwal, M., Samuels, B. A., Shufelt, C. L., Eastwood, J. A., Berman, D., Merz, N. B., & Minissian, M. B. (2017). Role of Stress Cardiac Magnetic Resonance Imaging in Women with Suspected Ischemia but No Obstructive Coronary Artery Disease. Journal of radiology nursing, 36(3), 180-183. https://doi.org/10.1016/j.jradnu.2017.04.016
Jalnapurkar, Sawan, et al. "Role of Stress Cardiac Magnetic Resonance Imaging in Women with Suspected Ischemia but No Obstructive Coronary Artery Disease." Journal of radiology nursing vol. 36,3 (2017): 180-183. doi: https://doi.org/10.1016/j.jradnu.2017.04.016
Jalnapurkar S, Zarrini P, Mehta PK, Thomson LEJ, Agarwal M, Samuels BA, Shufelt CL, Eastwood JA, Berman D, Merz NB, Minissian MB. Role of Stress Cardiac Magnetic Resonance Imaging in Women with Suspected Ischemia but No Obstructive Coronary Artery Disease. J Radiol Nurs. 2017 Sep;36(3):180-183. doi: 10.1016/j.jradnu.2017.04.016. Epub 2017 Aug 30. PMID: 29081724; PMCID: PMC5654630.
Copy Download .nbib Format: NLM
Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study.

Cardiovascular endocrinology

Khaliq A, Johnson BD, Anderson RD, Bavry AA, Cooper-DeHoff RM, Handberg EM, Bairey Merz CN, Nicholls SJ, Nissen S, Pepine CJ.
PMID: 26665010
Cardiovasc Endocrinol. 2015 Jun;4(2):45-52. doi: 10.1097/XCE.0000000000000049.

OBJECTIVE: In women, metabolic syndrome (MetS) is associated with higher risk of ischemic heart disease-related adverse outcomes versus individual components. We examined the relationship of MetS to subclinical coronary atherosclerosis.METHODS: Women (RESULTS: Detailed IVUS measurements were available in 87...

Cite
Khaliq A, Johnson BD, Anderson RD, et al. Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study. Cardiovasc Endocrinol. 2015;4(2):45-52doi: 10.1097/XCE.0000000000000049.
Khaliq, A., Johnson, B. D., Anderson, R. D., Bavry, A. A., Cooper-DeHoff, R. M., Handberg, E. M., Bairey Merz, C. N., Nicholls, S. J., Nissen, S., & Pepine, C. J. (2015). Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study. Cardiovascular endocrinology, 4(2), 45-52. https://doi.org/10.1097/XCE.0000000000000049
Khaliq, Asma, et al. "Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study." Cardiovascular endocrinology vol. 4,2 (2015): 45-52. doi: https://doi.org/10.1097/XCE.0000000000000049
Khaliq A, Johnson BD, Anderson RD, Bavry AA, Cooper-DeHoff RM, Handberg EM, Bairey Merz CN, Nicholls SJ, Nissen S, Pepine CJ. Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study. Cardiovasc Endocrinol. 2015 Jun;4(2):45-52. doi: 10.1097/XCE.0000000000000049. PMID: 26665010; PMCID: PMC4671302.
Copy Download .nbib Format: NLM
Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus.

JAMA cardiology

Quesada O, Shufelt C, Bairey Merz CN.
PMID: 32936208
JAMA Cardiol. 2020 Dec 01;5(12):1398-1400. doi: 10.1001/jamacardio.2020.4117.

No abstract available.

Cite
Quesada O, Shufelt C, Bairey Merz CN. Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus. JAMA Cardiol. 2020;5(12):1398-1400doi: 10.1001/jamacardio.2020.4117.
Quesada, O., Shufelt, C., & Bairey Merz, C. N. (2020). Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus. JAMA cardiology, 5(12), 1398-1400. https://doi.org/10.1001/jamacardio.2020.4117
Quesada, Odayme, et al. "Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus." JAMA cardiology vol. 5,12 (2020): 1398-1400. doi: https://doi.org/10.1001/jamacardio.2020.4117
Quesada O, Shufelt C, Bairey Merz CN. Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus. JAMA Cardiol. 2020 Dec 01;5(12):1398-1400. doi: 10.1001/jamacardio.2020.4117. PMID: 32936208; PMCID: PMC8074640.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries